Novartis says Entresto linked to higher quality of life scores

ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday that a new analysis showed its Entresto drug was linked to higher quality of life scores among patients who had been hospitalized with reduced ejection fraction heart failure.